1. Post-market digital therapy products focusing on prevention and health management have two ways of reaching them before they enter the coverage of commercial insurance and medical insurance: 2C and 2B2C.
2. 2C: Directly facing C-end consumers. Unlike other chronic disease management or electronic products, 2C digital therapies have the status of OTC over-the-counter drugs, have more medical value, and focus on the prevention or management of diseases.
3. The 2C business model requires digital therapy developers to spend a long time in early patient education. Make full use of KOL, activities, live broadcasts and other communication methods to make patients generally aware that digital therapy is a relatively effective treatment method.